Recent Developments and Achievements at Hi-Q Marine Biotech #
Hi-Q Marine Biotech continues to make significant strides in both scientific research and community engagement. Below is a curated selection of the latest news and milestones that showcase our ongoing commitment to innovation, health, and social responsibility.
Empowering Future Leaders with Kindness and Integrity : Hi-Q Scholarship Awards
Dr. Chen Wei-Hua, Brand Ambassador of Hi-Q ONCOFUCO, Receives the 28th Fervent Global Love of Lives Award, Featured in Multiple Media Outlets
Hi-Q's ONCOFUCO® and BALANGLUCO® Products Receive SNQ Certification
New Research Publication: OliFuco® Oligo Fucoidan Attenuates Cardiac Remodeling by Inhibiting Galectin-3 Secretion, Fibrosis, and Inflammation in a Mouse Model of Pressure Overload
Hi-Q ONCOFUCO Dominates Taiwan's Fucoidan Industry
Supporting Pink Ribbon Month with the Taiwan Breast Cancer Foundation
2024 Agricultural Value-Added Processing Industry Forum
Hi-Q Proudly Supports the 1919 After-School Tutoring for Disadvantaged Children
New Research Publication: OliFuco® Oligo Fucoidan as an Adjunct Therapy for Lung Cancer
The New Launch of COSMOS Approved FucoSkin® CS
Hi-Q’s Ocean Challenge: Strengthening Body and Protecting Seas through Open Water Swimming
Explore Our Latest Interview with Fortune Magazine/Voices of Leaders
Empowering Future Leaders with Kindness and Integrity: Hi-Q Scholarship Awards #
On June 10th, Hi-Q hosted a joint scholarship ceremony at the Hi-Q Brand House, celebrating students from National Taiwan Ocean University (NTOU) who exemplify academic dedication and a spirit of service. This initiative reflects our belief that true success is measured not only by innovation but also by giving back to the community. Read more
Dr. Chen Wei-Hua Honored with the 28th Fervent Global Love of Lives Award #
Dr. Wei-Hua Chen, a renowned cardiologist and director of Hongxin Clinic in Taichung, Taiwan, has received the 28th Fervent Global Love of Lives Award from the Chou Ta-Kuan Cultural and Educational Foundation. Having battled four types of cancer over two decades, Dr. Chen is recognized for his resilience, contributions to patient care, rural medicine, and global advocacy. Read more
ONCOFUCO® and BALANGLUCO® Achieve SNQ Certification #
Hi-Q Marine Biotech is proud to announce that ONCOFUCO® and BALANGLUCO®, two flagship products, have received SNQ certification for 2025, underscoring our commitment to quality and safety. Read more
Research Breakthrough: OliFuco® Oligo Fucoidan and Cardiac Health #
A new study led by Dr. Wen-Rui Hao from the Division of Cardiology, Shuang Ho Hospital, demonstrates that OliFuco® Oligo Fucoidan can attenuate cardiac remodeling by inhibiting galectin-3 secretion, fibrosis, and inflammation in a mouse model. The findings are published in the journal Biomedicines. Read more
ONCOFUCO: Leading Taiwan’s Fucoidan Industry #
ONCOFUCO Oligo Fucoidan has become the top brand in Taiwan’s fucoidan market, ranking first in both brand recognition and market share. The product has earned 20 internationally recognized certifications, highlighting its industry authority. Read more
Supporting Pink Ribbon Month with the Taiwan Breast Cancer Foundation #
Hi-Q Marine Biotech is honored to support the Taiwan Breast Cancer Foundation in promoting breast cancer awareness and early prevention, aligning with our commitment to community health and well-being. Read more
Participation in the 2024 Agricultural Value-Added Processing Industry Forum #
Hi-Q was honored to participate in the 2024 Agricultural Value-Added Processing Industry Forum, hosted by the Ministry of Agriculture at National Taiwan University International Conference Center, contributing to discussions on industry innovation. Read more
Supporting the 1919 After-School Tutoring for Disadvantaged Children #
Hi-Q remains deeply committed to community support, serving as a main sponsor for the 1919 After-School Tutoring program for disadvantaged children, an initiative we have supported for many years. Read more
OliFuco® Oligo Fucoidan as an Adjunct Therapy for Lung Cancer #
A recent study explores the use of OliFuco® Oligo Fucoidan as an adjunct therapy for lung cancer, focusing on its potential to improve patient outcomes when combined with conventional treatments. Read more
Launch of COSMOS Approved FucoSkin® CS #
Hi-Q announces the launch of FucoSkin® CS, a new raw material certified as COSMOS Approved by Ecocert. This product reflects our dedication to sustainable beauty and responsible use of natural resources. Read more
Ocean Challenge: Promoting Health and Marine Conservation #
Hi-Q’s founder and co-founder, both over 70 years old, participated in an open water swimming event in Green Island, Taiwan, demonstrating the importance of a healthy lifestyle and environmental stewardship. Read more
Interview with Fortune Magazine: Bridging the Cancer Care Gap #
Hi-Q was recently featured in Fortune Magazine’s “Voices of Leaders,” discussing our pivotal role in developing innovative supplementary health products to bridge the cancer care gap. Read more